Literature DB >> 11297593

Cellular localization of orexin receptors in human pituitary.

M Blanco1, M López, T García-Caballero, R Gallego, A Vázquez-Boquete , G Morel, R Señarís, F Casanueva, C Diéguez, A Beiras.   

Abstract

Orexins-A and -B are hypothalamic peptides derived from a precursor called prepro-orexin and relationated with the stimulation of food intake. They act on G protein receptors named orexin receptor 1 (OX(1)R) and orexin receptor 2 (OX(2)R), respectively. In the present study, we used RT-PCR and immunohistochemical techniques to detect the presence of OX(1)R and OX(2)R in human pituitary. A band of the expected size for both OX(1)R and OX(2)R was shown in human pituitary by RT-PCR. The cellular localization of OX(1)R and OX(2)R was carried out using histological techniques. By consecutive sections we demonstrated that OX(1)R was present in acidophil, diffusely distributed cells, which represent the half of the total adenohypophysis cell population. As was expected, these cells were shown to coexpress GH. OX(2)R was found in the pars intermedia and in clusters of basophil cells of the anterior pituitary, which coexpress ACTH. These results were confirmed by double immunofluorescence techniques. We also found focal positivity in axon terminals of neurohypophysis, more intense for OX(2)R than for OX(1)R. In conclusion, these results demonstrated for the first time that OX(1)R and OX(2)R were expressed by somatotrope and corticotrope cells, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297593

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Cellular localization of orexins in human anterior pituitary.

Authors:  Montserrat Blanco; Rosalía Gallego; Tomás García-Caballero; Carlos Diéguez; Andrés Beiras
Journal:  Histochem Cell Biol       Date:  2003-08-28       Impact factor: 4.304

2.  Glucagon regulates orexin A secretion in humans and rodents.

Authors:  Ayman M Arafat; Przemysław Kaczmarek; Marek Skrzypski; Ewa Pruszyńska-Oszmałek; Paweł Kołodziejski; Aikaterini Adamidou; Stephan Ruhla; Dawid Szczepankiewicz; Maciej Sassek; Maria Billert; Bertram Wiedenmann; Andreas F H Pfeiffer; Krzysztof W Nowak; Mathias Z Strowski
Journal:  Diabetologia       Date:  2014-07-27       Impact factor: 10.122

Review 3.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.

Authors:  Ravid Sasson; Robert K Dearth; Rachel S White; Patrick E Chappell; Pamela L Mellon
Journal:  Neuroendocrinology       Date:  2006-12-28       Impact factor: 4.914

5.  Orexin a stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity.

Authors:  Griselda Moreno; Mario Perelló; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

6.  Merkel cells, a new localization of prepro-orexin and orexin receptors.

Authors:  Andrés Beiras-Fernández; Rosalía Gallego; Montserrat Blanco; Tomás García-Caballero; Carlos Diéguez; Andrés Beiras
Journal:  J Anat       Date:  2004-02       Impact factor: 2.610

7.  The in vitro regulation of growth hormone secretion by orexins.

Authors:  Chen Chen; Ruwei Xu
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

8.  Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.

Authors:  Daisuke Nishizawa; Shinya Kasai; Junko Hasegawa; Naomi Sato; Hidetaka Yamada; Fumihiko Tanioka; Makoto Nagashima; Ryoji Katoh; Yasuo Satoh; Megumi Tagami; Hiroshi Ujike; Norio Ozaki; Toshiya Inada; Nakao Iwata; Ichiro Sora; Masaomi Iyo; Mitsuhiko Yamada; Naoki Kondo; Moo-Jun Won; Nobuya Naruse; Kumi Uehara-Aoyama; Masanari Itokawa; Kazutaka Ohi; Ryota Hashimoto; Kumpei Tanisawa; Tomio Arai; Seijiro Mori; Motoji Sawabe; Makiko Naka-Mieno; Yoshiji Yamada; Miki Yamada; Noriko Sato; Masaaki Muramatsu; Masashi Tanaka; Yoko Irukayama-Tomobe; Yuki C Saito; Takeshi Sakurai; Masakazu Hayashida; Haruhiko Sugimura; Kazutaka Ikeda
Journal:  Mol Brain       Date:  2015-08-20       Impact factor: 4.041

9.  Reduced plasma orexin-A levels in patients with bipolar disorder.

Authors:  Shoko Tsuchimine; Kotaro Hattori; Miho Ota; Shinsuke Hidese; Toshiya Teraishi; Daimei Sasayama; Hiroaki Hori; Takamasa Noda; Sumiko Yoshida; Fuyuko Yoshida; Hiroshi Kunugi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-06       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.